Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736 |
Resumo: | Introduction: Methicillin-resistant Staphylococcus aureus remains one of the principal resistant pathogens causing serious healthcareassociated infections. The objective of this study was to control and monitor methicillin-resistant Staphylococcus aureus cases using multimodal strategy in a Portuguese hospital.Material and Methods: Multistep procedure involving isolation measures and active surveillance cultures in a selected population (patients from other hospitals and nursing homes; history of hospitalization/ methicillin-resistant Staphylococcus aureus; intensive and intermediate care patients and, in other inpatient services, direct contacts of newly detected methicillin-resistant Staphylococcus aureus patients and, since 2012, patients doing hemodialysis). Other parallel activities: (a) review of isolation and standard precautions policy, (b) reinforcement of alcohol-based handrubs at point of patient care, (c) information sessions to health professionals, (d) targeted information flyer for health professionals, (e) information leaflet for patients/ visitors; (f) procedure monitoring by audit (g) patient decolonization in intensive and intermediate care units, with follow-up screenings.Results: Between 2007 and 2012, methicillin-resistant Staphylococcus aureus surveillance detected a decrease in proportion from 66% to 57% and, in density of incidence, from 1.80 to 0.68 cases per thousand days of hospitalization (p < 0.001; RR 0.38; CI95%: 0.29-0.49).Discussion/Conclusion: According to published European data, using blood and cerebrospinal fluid isolates only, Portugal was the country with the highest level of methicillin-resistant Staphylococcus aureus in 2011. Using this inclusion criteria, our hospital reveled a proportion of methicillin-resistant Staphylococcus aureus below its national level (34% versus 55%) in 2011. Fighting methicillinresistant Staphylococcus aureus using a multimodal strategy is being effective in a high endemic level hospital, but perseverance is needed through continuous surveillance of cases, feed-back to professionals and procedure audits. |
id |
RCAP_d06953fefe89abb5145fab419b6f30dd |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/4736 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a HospitalEstratégia para Controlar o Staphylococcus Aureus Resistente à Meticilina: A Experiência de Cinco Anos de um HospitalIntroduction: Methicillin-resistant Staphylococcus aureus remains one of the principal resistant pathogens causing serious healthcareassociated infections. The objective of this study was to control and monitor methicillin-resistant Staphylococcus aureus cases using multimodal strategy in a Portuguese hospital.Material and Methods: Multistep procedure involving isolation measures and active surveillance cultures in a selected population (patients from other hospitals and nursing homes; history of hospitalization/ methicillin-resistant Staphylococcus aureus; intensive and intermediate care patients and, in other inpatient services, direct contacts of newly detected methicillin-resistant Staphylococcus aureus patients and, since 2012, patients doing hemodialysis). Other parallel activities: (a) review of isolation and standard precautions policy, (b) reinforcement of alcohol-based handrubs at point of patient care, (c) information sessions to health professionals, (d) targeted information flyer for health professionals, (e) information leaflet for patients/ visitors; (f) procedure monitoring by audit (g) patient decolonization in intensive and intermediate care units, with follow-up screenings.Results: Between 2007 and 2012, methicillin-resistant Staphylococcus aureus surveillance detected a decrease in proportion from 66% to 57% and, in density of incidence, from 1.80 to 0.68 cases per thousand days of hospitalization (p < 0.001; RR 0.38; CI95%: 0.29-0.49).Discussion/Conclusion: According to published European data, using blood and cerebrospinal fluid isolates only, Portugal was the country with the highest level of methicillin-resistant Staphylococcus aureus in 2011. Using this inclusion criteria, our hospital reveled a proportion of methicillin-resistant Staphylococcus aureus below its national level (34% versus 55%) in 2011. Fighting methicillinresistant Staphylococcus aureus using a multimodal strategy is being effective in a high endemic level hospital, but perseverance is needed through continuous surveillance of cases, feed-back to professionals and procedure audits.Introdução: O Staphylococcus aureus resistente à meticilina é um dos microrganismos multirresistentes mais frequentemente implicados em infeções associadas a cuidados de saúde. Definiu-se como objetivo implementar uma estratégia multimodal para controlar este microrganismo num hospital.Material e Métodos: Procedimento baseado em rastreio ativo e medidas de isolamento numa população selecionada (doentes provenientes de outras instituições de saúde e lares ou com historial de internamento/ staphylococcus aureus resistente à meticilina; doentes dos cuidados intensivos e intermédios e, nos restantes serviços, rastreio aos contactos diretos se detetado um novo caso de staphylococcus aureus resistente à meticilina e, desde 2012, hemodialisados). Outras ações paralelas: (1) revisão das normas Precauções Básicas e Isolamento; (2) reforço dos pontos de desinfeção alcoólica das mãos; (3) sessões de esclarecimento aos profissionais de saúde; (4) folha ‘Alerta de staphylococcus aureus resistente à meticilina’ no processo dos doentes; (5) panfleto de informação aos doentes/ visitas; (6) monitorização do procedimento através de auditoria e (7) descolonização de doentes nos cuidados intensivos e intermédios, com rastreios de follow-up.Resultados: Entre 2007 e 2012 registou-se um decréscimo da proporção de staphylococcus aureus resistente à meticilina de 66% para 57% e da densidade de incidência de 1,80 para 0,68 casos por mil dias de internamento (p < 0,001; RR 0,38; IC95%: 0,29-0,49).Discussão/Conclusão: De acordo com dados europeus publicados, referentes a isolados no sangue e líquor, Portugal foi o país com maior proporção de staphylococcus aureus resistente à meticilina em 2011. Utilizando este critério de inclusão, o nosso hospital revelou uma proporção de staphylococcus aureus resistente à meticilina inferior à média nacional (34% versus 55%). A estratégia multimodal demonstrou ser eficaz na diminuição dos casos de staphylococcus aureus resistente à meticilina. Salvaguarda-se a necessidade de realizar vigilância epidemiológica deste agente, bem como monitorização da aplicação do procedimento, com feedback aos profissionais de saúde.Ordem dos Médicos2014-02-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736oai:ojs.www.actamedicaportuguesa.com:article/4736Acta Médica Portuguesa; Vol. 27 No. 1 (2014): January-February; 67-72Acta Médica Portuguesa; Vol. 27 N.º 1 (2014): Janeiro-Fevereiro; 67-721646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736/3879https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736/3961Peres, DavidNeves, IsabelVieira, FernandaDevesa, Ildainfo:eu-repo/semantics/openAccess2022-12-20T11:03:59Zoai:ojs.www.actamedicaportuguesa.com:article/4736Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:18:58.139010Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital Estratégia para Controlar o Staphylococcus Aureus Resistente à Meticilina: A Experiência de Cinco Anos de um Hospital |
title |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
spellingShingle |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital Peres, David |
title_short |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
title_full |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
title_fullStr |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
title_full_unstemmed |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
title_sort |
Strategy to Control Methicillin-Resistant Staphylococcus Aureus: The 5 Year Experience of a Hospital |
author |
Peres, David |
author_facet |
Peres, David Neves, Isabel Vieira, Fernanda Devesa, Ilda |
author_role |
author |
author2 |
Neves, Isabel Vieira, Fernanda Devesa, Ilda |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Peres, David Neves, Isabel Vieira, Fernanda Devesa, Ilda |
description |
Introduction: Methicillin-resistant Staphylococcus aureus remains one of the principal resistant pathogens causing serious healthcareassociated infections. The objective of this study was to control and monitor methicillin-resistant Staphylococcus aureus cases using multimodal strategy in a Portuguese hospital.Material and Methods: Multistep procedure involving isolation measures and active surveillance cultures in a selected population (patients from other hospitals and nursing homes; history of hospitalization/ methicillin-resistant Staphylococcus aureus; intensive and intermediate care patients and, in other inpatient services, direct contacts of newly detected methicillin-resistant Staphylococcus aureus patients and, since 2012, patients doing hemodialysis). Other parallel activities: (a) review of isolation and standard precautions policy, (b) reinforcement of alcohol-based handrubs at point of patient care, (c) information sessions to health professionals, (d) targeted information flyer for health professionals, (e) information leaflet for patients/ visitors; (f) procedure monitoring by audit (g) patient decolonization in intensive and intermediate care units, with follow-up screenings.Results: Between 2007 and 2012, methicillin-resistant Staphylococcus aureus surveillance detected a decrease in proportion from 66% to 57% and, in density of incidence, from 1.80 to 0.68 cases per thousand days of hospitalization (p < 0.001; RR 0.38; CI95%: 0.29-0.49).Discussion/Conclusion: According to published European data, using blood and cerebrospinal fluid isolates only, Portugal was the country with the highest level of methicillin-resistant Staphylococcus aureus in 2011. Using this inclusion criteria, our hospital reveled a proportion of methicillin-resistant Staphylococcus aureus below its national level (34% versus 55%) in 2011. Fighting methicillinresistant Staphylococcus aureus using a multimodal strategy is being effective in a high endemic level hospital, but perseverance is needed through continuous surveillance of cases, feed-back to professionals and procedure audits. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-02-28 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736 oai:ojs.www.actamedicaportuguesa.com:article/4736 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/4736 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736/3879 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4736/3961 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 27 No. 1 (2014): January-February; 67-72 Acta Médica Portuguesa; Vol. 27 N.º 1 (2014): Janeiro-Fevereiro; 67-72 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130640593977344 |